YZR Capital

To add a bio or update investment portfolio, please click update information.

Investment Portfolio

Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery

14 Nov 2025

Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery

Scripta Therapeutics applies AI and experimental biology to map disease-driving transcription networks, aiming to identify new drug targets for neurodegenerative and complex conditions.

YZR Capital

- Life Sciences
1(12 months)
yzr-capital.com
Update Information

More venture news

Crimson
29 May 2026
Crimson closes a £1.9m seed round led by Y Combinator to expand its case intelligence platform built for litigation and arbitration teams
SeedLegal
Perceptic
28 May 2026
Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform
SeedLife Sciences
Zonova
26 May 2026
Zonova lands a £2.1m seed round from THENA Capital to prevent infection in medical devices
SeedHealth

YZR Capital

Investment Portfolio

Scripta Therapeutics raises £9m seed led by Oxford Science Enterprises and Apollo Health Ventures to upend conventional drug discovery

More venture news

Crimson closes a £1.9m seed round led by Y Combinator to expand its case intelligence platform built for litigation and arbitration teams

Perceptic raises a £9m seed round led by Accel to unify drug discovery and development on a single AI platform

Zonova lands a £2.1m seed round from THENA Capital to prevent infection in medical devices